About Christopher Moran, MD

Christopher J. Moran, MD, is an attending physician who treats patients in the MassGeneral Hospital for Children Pediatric Gastroenterology & Nutrition unit and the MassGeneral Hospital for Children Pediatric Inflammatory Bowel Disease Center. 

He is the director of the Pediatric GI Fellowship Program at MassGeneral Hospital for Children and has previously been the co-director of the Fellow Mentoring Program of NASPGHAN.

His research interests focus on the genetics of very early onset inflammatory bowel disease and using genetic testing to better understand inflammatory bowel disease and develop more targeted therapies for patients.

As part of the MGHfC Pediatric IBD Program, he frequently attends the MGHfC Pediatric Inflammatory Bowel Disease Parent-Patient Advisory Team events. 

 

Clinical Interests:

Treats:

Locations

Mass General for Children: Pediatric Gastroenterology & Nutrition Program
55 Fruit St.
Yawkey Center for Outpatient Care
Suite 6B
Boston, MA 02114
Phone: 617-726-8705

Mass General Brigham Healthcare Center at Foxborough
22 Patriot Place
Foxboro, MA 02035
Phone: 866-378-9164

Mass General for Children at Newton-Wellesley Hospital
2014 Washington St.
Newton, MA 02462
Phone: 617-243-6585

Medical Education

  • MD, Tufts University School of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Pediatric Gastroenterology, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Identification of Genetic Variants by Whole Exome Sequencing in Very Early Onset Inflammatory Bowel Disease

Comprehensive Analysis of Genetic Variation in Children with Inflammatory Bowel Disease

Determining the Role of Interleukin-10 Receptor Polymorphisms in Early-Onset Inflammatory Bowel Disease

Correlation of Histopathology with Disease Course in Pediatric Inflammatory Bowel Disease

Genetic Determinants of Therapy Response in Pediatric Inflammatory Bowel Disease

Publications

  • Ushiku T, Moran CJ, Lauwers GY. Focally enhanced gastritis in newly diagnosed pediatric inflammatory bowel disease. Am J Surg Path. 2013 Dec; 37(12):1882-8.

    Moran CJ, Walters T, Guo C, et. al. IL-10R Polymorphisms are Associated with Very Early-Onset Ulcerative Colitis Inflamm Bowel Dis. 2013 Jan; 19(1):115-23.

    Moy MP, Kaplan JL, Moran CJ, Winter HS, Gee MS MR Enterographic Findings as Biomarkers of Mucosal Healing in Young Patients with Crohn Disease. AJR Am J Roentgenol 2016 Jun 28:1-7

    Savarino J, Kaplan J, Winter H, Moran C, Israel E. Improving Clinical Remission Rates in Pediatric Inflammatory Bowel Disease with Pre-Visit Planning. BMJ Quality. 2016.

    Moran CJ, Kaplan JL, Winter HS. Genetic Variation Affects C-Reactive Protein Elevations in Crohn's disease. Inflamm Bowel Dis. 2018

    Moran CJ, Huang H, Rivas M, Kaplan JL, Daly MJ, Winter HS. Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis. PLoS One. 2018.

    Moran CJ, Noreck J, Winter HS, Li EX, Biller JA, Israel EJ, Kaplan JL. Additional Intestinal Mucosal Biopsy Sampling for Research is Safe During Pediatric Endoscopic Procedures. Clin Gastroenterol Hepatol 2019.

Reviews: Comments and Ratings